Dr. Kimberly Ann Bohjanen, MD

Dr. Bohjanen practices at M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota.

Dr. Bohjanen's NPI, 1447296660, was assigned on June 22, 2006. Dr. Bohjanen graduated from University Of Michigan Medical School in 1993. Dr. Bohjanen holds Minnesota license 42817.

Dr. Bohjanen's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis, at 909 Fulton Street Southeast, Minneapolis, MN 55455. The practice phone is (612) 676-5500.

Dr. Bohjanen's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota. Dr. Bohjanen is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Bohjanen to 4 more group practices and clinics and 3 medical groups, each named with a free account. Dr. Bohjanen's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bohjanen practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bohjanen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bohjanen is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bohjanen's licenses on file in 2 states: Minnesota and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Bohjanen treats.

CMS data shows 1,255 Medicare services from Dr. Bohjanen across 12 procedure codes in 2024, for 329 Medicare patients. Medicare paid $52,290 for them. Every service was in an office.

CMS counts 329 Medicare patients who saw Dr. Bohjanen in 2024. The largest group is 65 to 74, with 146 patients. 61% of them have high cholesterol, and 59% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bohjanen's median patient age at 58, with 64% women.

In 2024, Dr. Bohjanen wrote 1,704 Medicare Part D claims for 365 patients. 84% of them were for generic drugs. CMS names the drug for 1,503 of them, across 35 drugs with 11 or more claims each, at $1,485,549 in total drug cost. In 2023, CMS named 1,109 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bohjanen for performance year 2024, reported as part of a group. Dr. Bohjanen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bohjanen as offering telehealth. CMS counts 230 procedures of removal of skin lesions by Dr. Bohjanen, more than 80% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Bohjanen, published from 2009 to 2023. 2019 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Mycosis Fungoides and T-Lymphocytes. Dr. Bohjanen has published most often in J Am Acad Dermatol. Dr. Bohjanen's most frequent co-authors are Kavita Goyal, MD, Steven Tze-Wei Chen, MD, MPH and Georgios Pongas, MD.

CMS Open Payments shows 5 general payments to Dr. Bohjanen from 3 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 56% of the total. Seagen Inc. paid the most, $3,000.

Dmand AI lists 2 awards for Dr. Bohjanen, most recently CMS Stage 1 EHR in 2013.

Dr. Bohjanen graduated from University Of Michigan Medical School in 1993. Dr. Bohjanen is a member of AAD.

Dr. Bohjanen is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.